Skip to main content
Advertisement
Advertisement
PHIO
PHIO logo
Phio Pharmaceuticals Corp. Common Stock
0.80
USD
Sponsored
0.00
+0.16%
Nov 06, 15:59 UTC -5
Closed
exchange

Pre-Market

0.83

+0.03
+4.21%

Phio Pharmaceuticals Corp. Common Stock (PHIO) Profile

Phio Pharmaceuticals Corp. Common Stock Profile

About

Phio Pharmaceuticals Corp is focused on developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi therapeutic platform. The Company's pipeline consists of RXI-762 and RXI-804 which are in clinical stage. Phio Pharmaceuticals Corp, formerly known as RXi Pharmaceuticals Corporation, is based in Marlborough, United States.

Info & Links

CEO

Robert J. Bitterman

Headquarters

411 SWEDELAND ROAD, SUITE 23-1080
KING OF PRUSSIA, PA 19406, UNITED STATES

Sector

Medical

Auditor

GRANT THORNTON LLP

Share holders

14

Employees

6

Phio Pharmaceuticals Corp. Common Stock Statistics

Valuation Measures

Market Capitalization2

9.70M

Enterprise Value

-908.60K

Enterprise Value/EBITDA(ttm)

0.06

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.74

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-89.44%

Return on Invested Capital(ttm)

-117.18%

Return on Assets(ttm)

-82.73%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-15.23M

Net Income Available to Common(ttm)

-14.67M

Diluted EPS(ttm)

-1.21

Share Statistics

Beta (5Y Monthly)

0.93

52-Week Change

-48.63%

S&P 500 52-Week Change

14.38%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

11.95M

Dividend Yield

0.00%

Float4

11.21M

% Held by Insiders

3.52%

% Held by Institutions

57.31%

Balance Sheet

Total Cash(mrq)

10.61M

Total Cash Per Share(mrq)

0.89

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.19%

Quick Ratio(mrq)

8.39%

Book Value Per Share(mrq)

0.72

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.88

Free Cash Flow(ytd)

-10.31M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement